Treatment of vitreous hemorrhage in Rh-positive patients by intravitreal injection of anti-Rho-immunoglobulin.
22 Rh-positive patients suffering from vitreous hemorrhage caused by injuries to the eye, hypertension, or associated with subarachnoid hemorrhage, were treated with anti-Rh-immunoglobulin by intravitreal injection. 8 patients (36.4%) needed only one immunoglobulin injection and rapidly regained their former visual acuity. In 2 cases with repeated hemorrhage the result of the treatment was not satisfactory. The incidence of adverse effects was low.
D000328:Adult; D005128:Eye Diseases / Q000628:therapy; D005260:Female; D006470:Hemorrhage / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000008:administration & dosage; D007267:Injections; D008297:Male; D012204:Rh-Hr Blood-Group System / Q000276:immunology*; D018029:Rho(D) Immune Globulin; D014822:Vitreous Body
D007136:Immunoglobulins; D012204:Rh-Hr Blood-Group System; D018029:Rho(D) Immune Globulin